1. Home
  2. Labeler Index
  3. Kvk-tech, Inc.
  4. 10702-201
  5. Product Images: Oxybutynin Chloride

Product Images Oxybutynin Chloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Oxybutynin Chloride NDC 10702-201 by Kvk-tech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula - figure 1 structure

Structural Formula - figure 1 structure

1000s label - figure 10 1000s label

1000s label - figure 10 1000s label

This is a medication description for Oxybutynin Chioride USP tablets containing 5mg of the active ingredient. The recommended dosage is one tablet for adults two to four times a day and for pediatric patients, one tablet two or three times a day. The tablets should be dispensed in a light-resistant container and stored between 20°C to 25°C (68°F to 77°F). This medication is only available through prescription and should be kept out of reach of children. The manufacturer is KVK-Tech Inc. based in Newtown, PA.*

Table 1 - figure 2 table1

Table 1 - figure 2 table1

This appears to be a table indicating the results of a comparison of two parameters (R-Oybutynin and S-Ouybutynin) in terms of their G, Toa, AUC, and UGy values. The units of measurement are not immediately clear. The values for the two parameters appear to vary significantly across all four categories.*

Figure 1 - figure 3 figure1

Figure 1 - figure 3 figure1

Table 2 - figure 4 table2

Table 2 - figure 4 table2

Figure 2 - figure 5 figure2

Figure 2 - figure 5 figure2

Table 3 - figure 6 table3

Table 3 - figure 6 table3

Oxybutynin Chloride is a drug that may cause adverse events in multiple body systems such as infections, psychiatric disorders, nervous system disorders, eye disorders, gastrointestinal disorders, and renal and urinary disorders. These events include urinary tract infection, insomnia, nervousness, dizziness, somnolence, blurred vision, dry mouth, constipation, nausea, dyspepsia, urinary hesitation, and urinary retention. The percentages represent how often these events occurred in clinical trials.*

KVK logo - figure 7 company logo

KVK logo - figure 7 company logo

100s label - figure 8 100s label

100s label - figure 8 100s label

Each tablet contains Oxybutynin Chloride at a strength of 5mg. The tablets are USP 0sperseinatos sptessontconsosr s s. They should be stored at temperatures between 15°C to 37°C (60 to 98°F). The pack has 100 tablets and the tablets can be identified by NOG 10702.201-01 and NDC 10702-201-01. The product should be kept out of children's reach.*

500s label - figure 9 500s label

500s label - figure 9 500s label

This is a description of Oxybutynin Chloride Tablets, USP with 5mg strength. It is a prescription drug by KVK and is to be taken one tablet two to four times a day by adults, and one tablet two to three times a day by pediatric patients with precautions. It is recommended to store in a light-resistant container as defined in the USPIN and keep out of the reach of children. The manufacturer of this drug is KVICToch, Inc, located in Newtown, PA 16940.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.